Literature DB >> 24823886

Inflammation aggravates heterogeneity of ventricular repolarization in children with Kawasaki disease.

Masayuki Fujino1, Tadayoshi Hata, Marina Kuriki, Kayo Horio, Hidetoshi Uchida, Yoshihiko Eryu, Hiroko Boda, Masafumi Miyata, Tetsushi Yoshikawa.   

Abstract

Kawasaki disease complicates with myocarditis and vasculitis. Even if myocarditis is asymptomatic, heterogeneity of ventricular repolarization may be increased in the acute phase. We evaluated whether the change in repolarization characteristics can be used as a predictor for myocarditis and coronary lesions. Enrolled 34 children who were treated with intravenous immunoglobulin therapy. There were no sequelae in the recovery phase in any subjects, including those who had transient coronary artery lesion. QT and the interval from the Tpeak to Tend (Tp-e) were determined. The Tp-e/QT ratios were compared between the acute and recovery phases and correlations with CRP level and body temperature were evaluated. A retrospective evaluation of Tp-e/QT as predictors of coronary dilation was also performed. Tp-e/QT in the acute phase correlated positively with body temperature and CRP level. In a comparison of patients with and without transient coronary artery lesion, Tp-e/QT was significantly higher in those with dilation. In conclusion, Tp-e/QT was strongly related to transient coronary dilation, in comparison with inflammatory indicators including fever and CRP level.

Entities:  

Mesh:

Year:  2014        PMID: 24823886     DOI: 10.1007/s00246-014-0926-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

1.  Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations.

Authors:  W L Atiga; L Fananapazir; D McAreavey; H Calkins; R D Berger
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

2.  Clinical application of rapid assay of serum interleukin-6 in Kawasaki disease.

Authors:  Yusuke Suganami; Hisashi Kawashima; Daisuke Hasegawa; Satoshi Sato; Akinori Hoshika
Journal:  Pediatr Int       Date:  2008-04       Impact factor: 1.524

3.  Ventricular repolarization lability in children with Kawasaki disease.

Authors:  Marina Kuriki; Masayuki Fujino; Ken-ichi Tanaka; Kayo Horio; Hirofumi Kusuki; Misa Hosoi; Yoshihiko Eryu; Tomochika Kato; Toshio Yamazaki; Tadayoshi Hata
Journal:  Pediatr Cardiol       Date:  2011-02-23       Impact factor: 1.655

4.  Coronary arterial involvement and QT dispersion in Kawasaki disease.

Authors:  M Osada; Y Tanaka; T Komai; Y Maeda; M Kitano; S Komori; K Tamura; H Sugiyama; J Yanai; S Nakazawa
Journal:  Am J Cardiol       Date:  1999-08-15       Impact factor: 2.778

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

Review 6.  T(p-e)/QT ratio as an index of arrhythmogenesis.

Authors:  Prasad Gupta; Chinmay Patel; Harsh Patel; Srinivasa Narayanaswamy; Binu Malhotra; Jared T Green; Gan-Xin Yan
Journal:  J Electrocardiol       Date:  2008-09-14       Impact factor: 1.438

7.  Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.

Authors:  Konstantinos P Letsas; Reinhold Weber; Klaus Astheimer; Dietrich Kalusche; Thomas Arentz
Journal:  Europace       Date:  2009-11-06       Impact factor: 5.214

8.  Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease.

Authors:  Tohru Kobayashi; Yoshinari Inoue; Tetsuya Otani; Akihiro Morikawa; Tomio Kobayashi; Kazuo Takeuchi; Tsutomu Saji; Tomoyoshi Sonobe; Shunichi Ogawa; Masaru Miura; Hirokazu Arakawa
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

9.  Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.

Authors:  C Y Lin; C C Lin; B Hwang; B Chiang
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

10.  Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Satoshi Tsuboi; Yasuko Aoyama; Kazuhiko Kotani; Enkh-Oyun Tsogzolbaatar; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2012-03-10       Impact factor: 3.211

View more
  3 in total

Review 1.  T-Wave Indices and Atherosclerosis.

Authors:  Gary Tse; George Bazoukis; Leonardo Roever; Tong Liu; William K K Wu; Martin C S Wong; Adrian Baranchuk; Panagiotis Korantzopoulos; Dimitrios Asvestas; Konstantinos P Letsas
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

2.  Electrocardiographic Analysis of Repolarization Changes in South Indian Children with Kawasaki Disease after the Acute Phase of Illness.

Authors:  Siddhartha Reddy; Maneesh Rai; Ravi Raj Singh Chouhan; Suchetha Rao; Nutan Kamath
Journal:  Int J Pediatr       Date:  2018-07-02

3.  Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.

Authors:  Xuting Zhang; Yuee He; Yiping Shao; Biyao Hang; Zhipeng Xu; Maoping Chu
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-26       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.